- Cooper, Dan M;
- Zulu, Michael Z;
- Jankeel, Allen;
- Ibraim, Izabela Coimbra;
- Ardo, Jessica;
- Kasper, Kirsten;
- Stephens, Diana;
- Meyer, Andria;
- Stehli, Annamarie;
- Condon, Curt;
- Londoño, Mary E;
- Schreiber, Casey M;
- Lopez, Nanette V;
- Camplain, Ricky L;
- Weiss, Michael;
- Golden, Charles;
- Radom-Aizik, Shlomit;
- Boden-Albala, Bernadette;
- Chau, Clayton;
- Messaoudi, Ilhem;
- Ulloa, Erlinda R
Background
Understanding SARS-CoV-2 infection in children is necessary to reopen schools safely.Methods
We measured SARS-CoV-2 infection in 320 learners [10.5 ± 2.1 (sd); 7-17 y.o.] at four diverse schools with either remote or on-site learning. Schools A and B served low-income Hispanic learners; school C served many special-needs learners, and all provided predominantly remote instruction. School D served middle- and upper-income learners, with predominantly on-site instruction. Testing occurred in the fall (2020), and 6-8 weeks later during the fall-winter surge (notable for a tenfold increase in COVID-19 cases). Immune responses and mitigation fidelity were also measured.Results
We found SARS-CoV-2 infections in 17 learners only during the surge. School A (97% remote learners) had the highest infection (10/70, 14.3%, p < 0.01) and IgG positivity rates (13/66, 19.7%). School D (93% on-site learners) had the lowest infection and IgG positivity rates (1/63, 1.6%). Mitigation compliance [physical distancing (mean 87.4%) and face-covering (91.3%)] was remarkably high at all schools. Documented SARS-CoV-2-infected learners had neutralizing antibodies (94.7%), robust IFN-γ + T cell responses, and reduced monocytes.Conclusions
Schools can implement successful mitigation strategies across a wide range of student diversity. Despite asymptomatic to mild SARS-CoV-2 infection, children generate robust humoral and cellular immune responses.Impact
Successful COVID-19 mitigation was implemented across a diverse range of schools. School-associated SARS-CoV-2 infections reflect regional rates rather than remote or on-site learning. Seropositive school-aged children with asymptomatic to mild SARS-CoV-2 infections generate robust humoral and cellular immunity.